Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 USD | -0.38% | +1.01% | +32.40% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 72.1M |
---|---|---|---|---|---|
Net income 2024 * | -81M | Net income 2025 * | -89M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-0.83
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.75% |
Latest transcript on Assembly Biosciences, Inc.
1 day | -1.71% | ||
1 week | +1.01% | ||
Current month | +4.49% | ||
1 month | -9.51% | ||
3 months | +5.42% | ||
6 months | +23.97% | ||
Current year | +32.40% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 20-03-29 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | Nov. 07 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 17-12-13 |
Gina Consylman
BRD | Director/Board Member | 52 | 20-10-19 |
William Ringo
CHM | Chairman | 78 | 14-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 13.1 | -0.38% | 4 581 |
24-05-03 | 13.15 | +2.65% | 4,556 |
24-05-02 | 12.81 | -3.47% | 20,698 |
24-05-01 | 13.27 | +6.42% | 12,287 |
24-04-30 | 12.47 | -3.33% | 11,821 |
Delayed Quote Nasdaq, May 06, 2024 at 11:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.40% | 72.1M | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-25.12% | 2.23B | |
+19.51% | 2.02B | |
+4.66% | 1.69B |
- Stock Market
- Equities
- ASMB Stock